A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Adam Hansen et al, adding:
”Peptide-mediated inhibition of surface-initiated thrombogenesis
A designed peptide, P12, blocked thrombus formation triggered by artificial surfaces while leaving normal clotting intact.
In testing, it curbed surface-initiated thrombogenesis without impairing physiological hemostasis.
The authors see translational promise for treating device-related thrombosis and for engineering antithrombotic surfaces and coatings that resist clotting without raising bleeding risk.”
Title: Peptide-mediated inhibition of surface-initiated thrombogenesis
Authors: Adam Hansen, Bernard Essuman, Georgios Kementzidis, Nabila Jaman Tripti, Fubao Lin, Volodymyr Chernyshenko, Richard A.F. Clark, Yuefan Deng, Miriam Rafailovich, Dennis Galanakis

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 08:43Rufiga Shari Abidin: Multi Organ Complications Detailed in COVID 19 Vaccine Adverse Event Study
-
Nov 10, 2026, 08:36Bahram Alamdary Badlou: Why Jak Inhibitors Demand Careful Monitoring In Chronic Inflammation Treatment?
-
Nov 10, 2026, 08:16Uyiekpen Ima-Edomwonyi: Why Autoimmune Inflammation Demands Early Vigilance?
-
Nov 10, 2026, 06:20Vida Shafti: Can AI Help Us Predict Thrombosis before it Happens in Assisted Reproduction?
-
Nov 10, 2026, 06:11Michaël Prüfer: Treatment of Varicose Veins with Laser Endoveineux Total
-
Nov 10, 2026, 05:55Sandhya Selvakumar: Guide to Stroke Classification and Rehabilitation
-
Nov 9, 2026, 22:47Avirup Guha: Early Immune Responses to Androgen Deprivation Therapy and Coronary Plaque Progression
-
Nov 9, 2026, 22:42Angela Forsyth: Joining Novo Nordisk as Medical Liaison for the Ohio Valley Region
-
Nov 9, 2026, 22:36Vladimir Otasevic: Presenting Thromboprophylaxis and Treatment of VTE in Patients With Malignancy